These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 20854792

  • 1. PPARα deficiency augments a ketogenic diet-induced circadian PAI-1 expression possibly through PPARγ activation in the liver.
    Oishi K, Uchida D, Ohkura N, Horie S.
    Biochem Biophys Res Commun; 2010 Oct 15; 401(2):313-8. PubMed ID: 20854792
    [Abstract] [Full Text] [Related]

  • 2. Proxisome proliferator-activated receptor-α mediates high-fat, diet-enhanced daily oscillation of plasminogen activator inhibitor-1 activity in mice.
    Hayashida S, Kuramoto Y, Koyanagi S, Oishi K, Fujiki J, Matsunaga N, Ikeda E, Ohdo S, Shimeno H, Soeda S.
    Chronobiol Int; 2010 Oct 15; 27(9-10):1735-53. PubMed ID: 20969520
    [Abstract] [Full Text] [Related]

  • 3. Bezafibrate induces plasminogen activator inhibitor-1 gene expression in a CLOCK-dependent circadian manner.
    Oishi K, Koyanagi S, Matsunaga N, Kadota K, Ikeda E, Hayashida S, Kuramoto Y, Shimeno H, Soeda S, Ohdo S.
    Mol Pharmacol; 2010 Jul 15; 78(1):135-41. PubMed ID: 20400680
    [Abstract] [Full Text] [Related]

  • 4. Ketogenic diet disrupts the circadian clock and increases hypofibrinolytic risk by inducing expression of plasminogen activator inhibitor-1.
    Oishi K, Uchida D, Ohkura N, Doi R, Ishida N, Kadota K, Horie S.
    Arterioscler Thromb Vasc Biol; 2009 Oct 15; 29(10):1571-7. PubMed ID: 19628783
    [Abstract] [Full Text] [Related]

  • 5. PPARγ activation induces acute PAI-1 gene expression in the liver but not in adipose tissues of diabetic model mice.
    Oishi K, Tomita T, Itoh N, Ohkura N.
    Thromb Res; 2011 Nov 15; 128(5):e81-5. PubMed ID: 21757225
    [Abstract] [Full Text] [Related]

  • 6. Circadian expression of FGF21 is induced by PPARalpha activation in the mouse liver.
    Oishi K, Uchida D, Ishida N.
    FEBS Lett; 2008 Oct 29; 582(25-26):3639-42. PubMed ID: 18840432
    [Abstract] [Full Text] [Related]

  • 7. Transgenic expression of mutant peroxisome proliferator-activated receptor gamma in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice.
    Tanaka T, Masuzaki H, Ebihara K, Ogawa Y, Yasue S, Yukioka H, Chusho H, Miyanaga F, Miyazawa T, Fujimoto M, Kusakabe T, Kobayashi N, Hayashi T, Hosoda K, Nakao K.
    Metabolism; 2005 Nov 29; 54(11):1490-8. PubMed ID: 16253638
    [Abstract] [Full Text] [Related]

  • 8. PERIOD2 is a circadian negative regulator of PAI-1 gene expression in mice.
    Oishi K, Miyazaki K, Uchida D, Ohkura N, Wakabayashi M, Doi R, Matsuda J, Ishida N.
    J Mol Cell Cardiol; 2009 Apr 29; 46(4):545-52. PubMed ID: 19168071
    [Abstract] [Full Text] [Related]

  • 9. Identification of promethin and PGLP as two novel up-regulated genes in PPARgamma1-induced adipogenic mouse liver.
    Yu S, Viswakarma N, Batra SK, Sambasiva Rao M, Reddy JK.
    Biochimie; 2004 Nov 29; 86(11):743-61. PubMed ID: 15589683
    [Abstract] [Full Text] [Related]

  • 10. Circadian expression of plasminogen activator inhibitor-1 in angiotensin II type 1a receptor knockout mice.
    Tsujino T, Naito Y, Kawasaki D, Okuda S, Sakoda T, Fujioka Y, Sugaya T, Ohyanagi M.
    Clin Exp Hypertens; 2005 Nov 29; 27(2-3):159-68. PubMed ID: 15835378
    [Abstract] [Full Text] [Related]

  • 11. Importance of PPAR alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism.
    Ljungberg A, Lindén D, Améen C, Bergström G, Oscarsson J.
    Growth Horm IGF Res; 2007 Apr 29; 17(2):154-64. PubMed ID: 17307376
    [Abstract] [Full Text] [Related]

  • 12. Inhibition by fibrates of plasminogen activator inhibitor type-1 expression in human adipocytes and preadipocytes.
    Zirlik A, Ernst S, Leugers A, Willecke F, Sobel BE, Bode C, Nordt TK.
    Thromb Haemost; 2009 Jun 29; 101(6):1060-9. PubMed ID: 19492148
    [Abstract] [Full Text] [Related]

  • 13. Involvement of circadian clock gene Clock in diabetes-induced circadian augmentation of plasminogen activator inhibitor-1 (PAI-1) expression in the mouse heart.
    Oishi K, Ohkura N, Amagai N, Ishida N.
    FEBS Lett; 2005 Jul 04; 579(17):3555-9. PubMed ID: 15950223
    [Abstract] [Full Text] [Related]

  • 14. PPARalpha is a potential therapeutic target of drugs to treat circadian rhythm sleep disorders.
    Shirai H, Oishi K, Kudo T, Shibata S, Ishida N.
    Biochem Biophys Res Commun; 2007 Jun 08; 357(3):679-82. PubMed ID: 17449013
    [Abstract] [Full Text] [Related]

  • 15. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.
    Hays T, Rusyn I, Burns AM, Kennett MJ, Ward JM, Gonzalez FJ, Peters JM.
    Carcinogenesis; 2005 Jan 08; 26(1):219-27. PubMed ID: 15447978
    [Abstract] [Full Text] [Related]

  • 16. Cholesterol diet enhances daily rhythm of Pai-1 mRNA in the mouse liver.
    Kudo T, Nakayama E, Suzuki S, Akiyama M, Shibata S.
    Am J Physiol Endocrinol Metab; 2004 Oct 08; 287(4):E644-51. PubMed ID: 15361354
    [Abstract] [Full Text] [Related]

  • 17. The transcriptional coactivator peroxisome proliferator activated receptor (PPAR)gamma coactivator-1 alpha and the nuclear receptor PPAR alpha control the expression of glycerol kinase and metabolism genes independently of PPAR gamma activation in human white adipocytes.
    Mazzucotelli A, Viguerie N, Tiraby C, Annicotte JS, Mairal A, Klimcakova E, Lepin E, Delmar P, Dejean S, Tavernier G, Lefort C, Hidalgo J, Pineau T, Fajas L, Clément K, Langin D.
    Diabetes; 2007 Oct 08; 56(10):2467-75. PubMed ID: 17646210
    [Abstract] [Full Text] [Related]

  • 18. Changes in liver PPARalpha mRNA expression in response to two levels of high-safflower-oil diets correlate with changes in adiposity and serum leptin in rats and mice.
    Hsu SC, Huang CJ.
    J Nutr Biochem; 2007 Feb 08; 18(2):86-96. PubMed ID: 16713235
    [Abstract] [Full Text] [Related]

  • 19. A role for PPARalpha in the control of SREBP activity and lipid synthesis in the liver.
    Knight BL, Hebbachi A, Hauton D, Brown AM, Wiggins D, Patel DD, Gibbons GF.
    Biochem J; 2005 Jul 15; 389(Pt 2):413-21. PubMed ID: 15777286
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.